Genome analysis has the potential to reveal valuable information about why some people develop serious obesity-related side effects and others don't. HealthMaker Daniel Kelly, MD, describes the potential for this research in this video.
That would be very helpful for us, and we're doing this, and other people are doing these studies, to understand a little bit more about the genome of these individuals, because it's probably not going to be a single 'Aha' moment with mutation in one gene, but there will be variations that come together that probably protect these individuals, and we would like to look and see if we look at those individuals and compare them to those who develop heart disease with only a modest increase, in obesity or a diet or insulin resistance in diabetes rapidly with obesity that we would compare those.
So that might be an opportunity for the genomic approach.
Daniel Kelly, MD, is senior vice president, Tavistock Distinguished Professor and scientific director of the Sanford-Burnham Medical Research Institute at Lake Nona. He specializes in heart disease, metabolic Syndrome, obesity and diabetes.
See All HealthMakers